RYE, N.Y., March 21, 2011 /PRNewswire/ — Curemark, LLC, (www.curemark.com), a drug research and development company focused on the treatment of neurological diseases, announced that the company has completed its targeted enrollment of Phase III
Read More...
Read the complete post at http://kiddieyap.com/2011/03/curemark-completes-enrollment-of-phase-iii-autism-trials/
Posted
Mar 21 2011, 04:59 AM
by
Kiddie Yaps